|
市場調査レポート
商品コード
1593486
プロテインA樹脂の市場規模・シェア・成長分析 (製品種類別、プロテインAの種類別、用途別、エンドユーザー別、地域別):産業予測 (2024~2031年)Protein A Resin Market Size, Share, Growth Analysis, By Product (Agarose-Based Protein A, Glass/Silica-Based Protein A), By Protein A Type (Recombinant Protein A, Natural Protein A), By Application, By End User, By Region - Industry Forecast 2024-2031 |
||||||
|
プロテインA樹脂の市場規模・シェア・成長分析 (製品種類別、プロテインAの種類別、用途別、エンドユーザー別、地域別):産業予測 (2024~2031年) |
出版日: 2024年11月10日
発行: SkyQuest
ページ情報: 英文 162 Pages
納期: 3~5営業日
|
世界のプロテインA樹脂の市場規模は、2022年に12億3,000万米ドルと評価され、2023年の13億5,000万米ドルから2031年には28億6,000万米ドルに成長し、予測期間 (2024~2031年) のCAGRは9.81%に達する見通しです。
プロテインA樹脂市場は、治療用タンパク質の生産と強化に不可欠な高品質のバイオ製造プロセスの推進において重要な役割を果たしています。この市場は製薬・バイオテクノロジー分野の重要なコンポーネントであり、主に抗体や様々な治療用タンパク質の効率的な精製の必要性によって牽引されています。生物製剤、モノクローナル抗体、個別化医薬品に対する需要の急増に加え、バイオテクノロジーや生産手法の進歩が続いていることが、市場の成長を後押ししています。しかし、コストが高い、規制要件が厳しい、樹脂の寿命が限られているなどの課題が障害となっています。とはいえ、持続可能な実践へのシフト、個別化医療と生物製剤への注目の高まりに後押しされ、市場は今後数年で大きな成長を遂げると予想されます。こうした動向が進化を続ける中、プロテインA樹脂市場は、バイオ製造プロセスの革新と効率化にとって引き続き重要であり、最終的には救命治療の生産を強化することになります。
Global Protein A Resin Market size was valued at USD 1.23 billion in 2022 and is poised to grow from USD 1.35 billion in 2023 to USD 2.86 billion by 2031, growing at a CAGR of 9.81% during the forecast period (2024-2031).
The Protein A resin market plays a vital role in advancing high-quality biomanufacturing processes essential for producing and enhancing therapeutic proteins. This market is a critical component of the pharmaceutical and biotechnology sectors, predominantly driven by the need for effective purification of antibodies and various therapeutic proteins. A surge in demand for biologics, monoclonal antibodies, and personalized medicines, alongside ongoing advancements in biotechnology and production methodologies, is propelling market growth. However, challenges such as high costs, stringent regulatory requirements, and the limited lifespan of resins pose obstacles. Nevertheless, the market is expected to experience significant growth in the coming years, propelled by a shift towards sustainable practices and an increasing focus on personalized medicine and biologics. As these trends continue to evolve, the Protein A resin market will remain crucial for the innovation and efficiency of biomanufacturing processes, ultimately enhancing the production of life-saving therapies.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Protein A Resin market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Protein A Resin Market Segmental Analysis
Global Protein A Resin Market is segmented by Product, Protein A Type, Application, End User, and Region. Based on Product, the market is segmented into Agarose-Based Protein A, Glass/Silica-Based Protein A, Organic Polymer-Based Protein A. Based on Protein A Type, the market is segmented into Recombinant Protein A, Natural Protein A. Based on Application, the market is segmented into Antibody Purification, Immunoprecipitation. Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Academic Research Institutes, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Protein A Resin Market
Improvements in biotechnology significantly drive the Global Protein A Resin market by enhancing the efficiency and effectiveness of antibody purification processes. As biopharmaceutical companies prioritize high-quality production, the demand for advanced purification technologies, including affinity chromatography utilizing Protein A resin, continues to rise. Innovations in resin design, such as increased binding capacity and reduced non-specific interactions, contribute to higher yields and cost-effectiveness, appealing to both established and emerging biopharma sectors. Furthermore, advancements in automation and scale-up processes bolster the adoption of Protein A resin, ultimately supporting the growing need for monoclonal antibodies and personalized medicine development within a rapidly evolving landscape.
Restraints in the Global Protein A Resin Market
One significant market restraint for the Global Protein A Resin market is the limited lifespan of these resins, which can hinder their cost-effectiveness and operational efficiency. Protein A resins, essential for the purification of antibodies and other proteins, often require regular replacement or regeneration due to factors such as steric hindrance, damage from cleaning procedures, or unsatisfactory binding capacity over time. This reduces the overall yield and increases the operational costs for companies relying on these resins in biopharmaceutical production. Consequently, the necessity for frequent maintenance and replacement may deter potential users and stifle market growth.
Market Trends of the Global Protein A Resin Market
The Global Protein A Resin market is witnessing a significant trend towards enhanced resin design and chemistry, driven by innovations aimed at increasing binding capabilities and reducing costs in antibody purification processes. Recent advancements in resin matrices and ligand chemistry have led to the development of highly stable ligands that withstand rigorous regeneration and cleaning protocols, thereby improving resin performance and longevity. Additionally, ongoing research into non-conventional ligands is opening new avenues for achieving similar binding efficiencies while minimizing dependence on traditional resins. This evolution is anticipated to propel market growth, increasing efficiency and cost-effectiveness across biopharmaceutical manufacturing.